Personalising treatments: lessons from history

13 April 2016 0

Fifty years ago, when I was just starting out in cancer medicine, our team at the cancer centre attached to Berlin’s Academy of Sciences began our attempts to individualise chemotherapy treatments. We knew that response [more]

Fifty years ago, when I was just starting out in cancer medicine, our team at the cancer centre attached to Berlin’s Academy of Sciences began our attempts to individualise chemotherapy treatments. ... [ more ]

Pulling together: the case for prostate cancer units

13 April 2016 0

People with cancer need their care managed by a team of specialists who work together and learn and improve together. Simon Crompton reports on efforts to achieve such a collaborative approach in delivering prostate cancer [more]

People with cancer need their care managed by a team of specialists who work together and learn and improve together. Simon Crompton reports on efforts to achieve such a collaborative approach in delivering prostate cancer care.... [ more ]

Is this the end for the microscope?

13 April 2016 0

New generations of precision digital scanners are threatening to replace the tool that has been the iconic symbol of pathology for so long. Maria Delaney reports. Glass slides containing tissues and cells are sitting in [more]

New generations of precision digital scanners are threatening to replace the tool that has been the iconic symbol of pathology for so long. Maria Delaney reports.... [ more ]

Ana Maria Forsea: getting from here to where we want to be

13 April 2016 0

With no data from a reliable registry, and no functional national cancer plan, Romania is destined to continue suffering some of the worst cancer rates in Europe. Vlad Mixich tells the story of one dermatologist [more]

With no data from a reliable registry, and no functional national cancer plan, Romania is destined to continue suffering some of the worst cancer rates in Europe. Vlad Mixich tells the story of one dermatologist who is doing...... [ more ]

Accelerating progress in immunotherapy

13 April 2016 0

The concept is attractive, the results in some patients have been stunning, but what will it take to extend these impressive responses to wider groups of patients? Peter McIntyre reports. There is a growing sense [more]

The concept is attractive, the results in some patients have been stunning, but what will it take to extend these impressive responses to wider groups of patients? Peter McIntyre reports.... [ more ]

Endoscopy in gastrointestinal oncology

12 April 2016 0

Once used primarily to detect large polyps and tumours, endoscopy has now become an essential tool for early diagnosis, curative treatment and palliation for gastrointestinal cancer. This is an edited version of a presentation delivered [more]

Once used primarily to detect large polyps and tumours, endoscopy has now become an essential tool for early diagnosis, curative treatment and palliation for gastrointestinal cancer.... [ more ]

Affordable cancer care: a global mirage?

12 April 2016 0

One of the great myths peddled about cancer control is that it is intrinsically affordable. Nothing could be further from the truth. Preventing and treating cancer is the pinnacle of the health system’s mountain. It [more]

One of the great myths peddled about cancer control is that it is intrinsically affordable. Nothing could be further from the truth. Preventing and treating cancer is the pinnacle of the health system’s mountain. ... [ more ]

Improving care for patients with rare cancers. Are European reference networks the answer?

12 April 2016 0

As the European Commission issues its first call for proposals to set up European reference networks, Anna Wagstaff asks: how can these cross-border healthcare structures improve the quality of care received by the almost half [more]

Are European reference networks the answer? As the European Commission issues its first call for proposals to set up European reference networks, Anna Wagstaff asks: how can these cross-border healthcare structures improve...... [ more ]

Novel approaches to pancreatic cancer

12 April 2016 0

With a five-year overall survival of less than 5%, there is an urgent need to explore new treatment paradigms for pancreatic cancer, including targeting stroma cells, cancer stem cells and metabolic pathways. Ignacio Garrido-Laguna and [more]

With a five-year overall survival of less than 5%, there is an urgent need to explore new treatment paradigms for pancreatic cancer, including targeting stroma cells, cancer stem cells and metabolic pathways. ... [ more ]

How doctors die. It’s not like the rest of us, but it should be

12 April 2016 0

This hard-hitting blogpost by Ken Murray, a retired Los Angeles family doctor, helped open up discussions about why doctors routinely administer treatments to dying patients that they would adamantly refuse for themselves. Years ago, Charlie, [more]

It’s not like the rest of us, but it should be. This hard-hitting blogpost by Ken Murray, a retired Los Angeles family doctor, helped open up discussions about why doctors routinely administer treatments to dying patients that...... [ more ]